Effect of Seasonal Malaria Chemoprevention on Immune Markers of Exhaustion and Regulation.

BACKGROUND Seasonal malaria chemoprevention (SMC) is a novel strategy to reduce malaria infections in children. Infection with Plasmodium falciparum results in immune dysfunction characterized by elevated expression of markers associated with exhaustion, such as PD1 and LAG3, and regulatory CD4+FOXP3+ T cells. METHODS In the current study, the impact of seasonal malaria chemoprevention on malaria-induced immune dysfunction, as measured by markers associated with exhaustion and regulatory T cells, was explored by flow cytometry. RESULTS Children that received seasonal malaria chemoprevention had fewer malaria episodes and showed significantly lower fold changes in CD4+PD1+ and CD4+PD1+LAG3+ compared to those that did not receive SMC. Seasonal malaria chemoprevention had no observable effect on fold changes in CD8 T cells expressing PD1 or CD160. However, children receiving SMC showed greater increases in CD4+FOXP3+ T regulatory cells compared to children not receiving SMC. CONCLUSIONS These results provide important insights into the dynamics of malaria-induced changes in the CD4 T-cell compartment of the immune system and suggest that the reduction of infections due to seasonal malaria chemoprevention may also prevent immune dysfunction. CLINICAL TRIALS REGISTRATION NCT02504918.

[1]  M. Addo,et al.  Differential expression pattern of co-inhibitory molecules on CD4+ T cells in uncomplicated versus complicated malaria , 2018, Scientific Reports.

[2]  Peter D. Crompton,et al.  Regulatory T cells impede acute and long-term immunity to blood-stage malaria through CTLA-4 , 2017, Nature Medicine.

[3]  E. Sartono,et al.  Longitudinal study of changes in γδ T cells and CD4+ T cells upon asymptomatic malaria infection in Indonesian children , 2017, Scientific Reports.

[4]  A. Dicko,et al.  Measuring the impact of seasonal malaria chemoprevention as part of routine malaria control in Kita, Mali , 2017, Malaria Journal.

[5]  A. Dicko,et al.  Effect of seasonal malaria chemoprevention on the acquisition of antibodies to Plasmodium falciparum antigens in Ouelessebougou, Mali , 2017, Malaria Journal.

[6]  T. Jacobs,et al.  Acute Malaria Induces PD1+CTLA4+ Effector T Cells with Cell-Extrinsic Suppressor Function , 2016, PLoS pathogens.

[7]  M. Laufer,et al.  Prolonged PD1 Expression on Neonatal Vδ2 Lymphocytes Dampens Proinflammatory Responses: Role of Epigenetic Regulation , 2016, The Journal of Immunology.

[8]  Thomas S. Watkins,et al.  Programmed Death-1 Ligand 2-Mediated Regulation of the PD-L1 to PD-1 Axis Is Essential for Establishing CD4(+) T Cell Immunity. , 2016, Immunity.

[9]  B. Cissé,et al.  Potential Impact of Seasonal Malaria Chemoprevention on the Acquisition of Antibodies against Glutamate-Rich Protein and Apical Membrane Antigen 1 in Children Living in Southern Senegal , 2015, American Journal of Tropical Medicine and Hygiene.

[10]  S. McSorley,et al.  Transient Loss of Protection Afforded by a Live Attenuated Non-typhoidal Salmonella Vaccine in Mice Co-infected with Malaria , 2015, PLoS neglected tropical diseases.

[11]  M. Feeney,et al.  Decline of FoxP3+ Regulatory CD4 T Cells in Peripheral Blood of Children Heavily Exposed to Malaria , 2015, PLoS pathogens.

[12]  Lucille Blumberg,et al.  Severe Malaria , 2014, Tropical medicine & international health : TM & IH.

[13]  Peter D. Crompton,et al.  Malaria immunity in man and mosquito: insights into unsolved mysteries of a deadly infectious disease. , 2014, Annual review of immunology.

[14]  M. Feeney,et al.  IFNγ/IL-10 Co-producing Cells Dominate the CD4 Response to Malaria in Highly Exposed Children , 2014, PLoS pathogens.

[15]  Peter D. Crompton,et al.  An intensive longitudinal cohort study of Malian children and adults reveals no evidence of acquired immunity to Plasmodium falciparum infection. , 2013, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[16]  Peter D. Crompton,et al.  Chronic Exposure to Plasmodium falciparum Is Associated with Phenotypic Evidence of B and T Cell Exhaustion , 2013, The Journal of Immunology.

[17]  F. Mackay,et al.  Malaria infection alters the expression of B‐cell activating factor resulting in diminished memory antibody responses and survival , 2012, European journal of immunology.

[18]  Peter D. Crompton,et al.  Therapeutic PD-L1 and LAG-3 blockade rapidly clears established blood-stage Plasmodium infection , 2011, Nature Immunology.

[19]  Kevin Marsh,et al.  Relation between falciparum malaria and bacteraemia in Kenyan children: a population-based, case-control study and a longitudinal study , 2011, The Lancet.

[20]  C. Newbold,et al.  Host-mediated regulation of superinfection in malaria , 2011, Nature Medicine.

[21]  Anne L. Wilson.  A Systematic Review and Meta-Analysis of the Efficacy and Safety of Intermittent Preventive Treatment of Malaria in Children (IPTc) , 2011, PloS one.

[22]  Yoshimasa Tanaka,et al.  Expression and function of PD‐1 in human γδ T cells that recognize phosphoantigens , 2011, European journal of immunology.

[23]  A. Dicko,et al.  Intermittent Preventive Treatment of Malaria Provides Substantial Protection against Malaria in Children Already Protected by an Insecticide-Treated Bednet in Mali: A Randomised, Double-Blind, Placebo-Controlled Trial , 2011, PLoS medicine.

[24]  S. Cousens,et al.  Intermittent Preventive Treatment of Malaria Provides Substantial Protection against Malaria in Children Already Protected by an Insecticide-Treated Bednet in Burkina Faso: A Randomised, Double-Blind, Placebo-Controlled Trial , 2011, PLoS medicine.

[25]  D. Conway,et al.  Homeostatic regulation of T effector to Treg ratios in an area of seasonal malaria transmission , 2009, European journal of immunology.

[26]  Kevin Marsh,et al.  Immunity to malaria: more questions than answers , 2008, Nature Immunology.

[27]  B. Cissé,et al.  Seasonal intermittent preventive treatment with artesunate and sulfadoxine-pyrimethamine for prevention of malaria in Senegalese children: a randomised, placebo-controlled, double-blind trial , 2006, The Lancet.

[28]  R. Sinden,et al.  Upregulation of TGF-beta, FOXP3, and CD4+CD25+ regulatory T cells correlates with more rapid parasite growth in human malaria infection. , 2005, Immunity.

[29]  E. Riley,et al.  Absolute levels and ratios of proinflammatory and anti-inflammatory cytokine production in vitro predict clinical immunity to Plasmodium falciparum malaria. , 2002, The Journal of infectious diseases.

[30]  A. Hayday,et al.  Regulated T‐cell development: a victim of multiple conspiracies , 2001, Immunology.

[31]  W E Collins,et al.  A retrospective examination of secondary sporozoite- and trophozoite-induced infections with Plasmodium falciparum: development of parasitologic and clinical immunity following secondary infection. , 1999, American Journal of Tropical Medicine and Hygiene.